2526 - 2550 of 6284 Results
Title
Year
- Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications2023OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645Best OA location URL: https://doi.org/10.7554/elife.91645Citation Count: 47
-
OPENTitle: Distinct subcellular localization of tau and alpha-synuclein in lewy body diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s40478-024-01913-wBest OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-024-01913-wCitation Count: 0
-
OPENTitle: Neuromelanin accumulation drives endogenous synucleinopathy in non-human primatesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: 5000End Page: 5014Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awad331Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad331/51792215/awad331.pdfCitation Count: 16
- Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s disease2020OPENTitle: Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s diseaseJournal Name: Cytokine: XPublisher: Elsevier BVVol: 2Issue #: 2Start Page: 100027End Page: 100027Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cytox.2020.100027Best OA location URL: https://doi.org/10.1016/j.cytox.2020.100027Citation Count: 42
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
-
OPENTitle: Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s DiseaseJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 212End Page: 224Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-018-0981-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-018-0981-y.pdfCitation Count: 20
-
OPENTitle: Stiripentol for the treatment of super-refractory status epilepticusJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 132Issue #: 6Start Page: 435End Page: 439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12403Best OA location URL: https://doi.org/10.1111/ane.12403Citation Count: 42
-
OPENTitle: Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 642End Page: 650Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28360Citation Count: 78
-
OPENTitle: Weighted Protein Interaction Network Analysis of Frontotemporal DementiaJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 16Issue #: 2Start Page: 999End Page: 1013Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jproteome.6b00934Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.6b00934Citation Count: 41
- TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration2021OPENTitle: TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respirationJournal Name: Cell ReportsPublisher: Elsevier BVVol: 34Issue #: 12Start Page: 108895End Page: 108895Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.108895Best OA location URL: http://www.cell.com/article/S2211124721002096/pdfCitation Count: 49
- Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment2012OPENTitle: Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairmentJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 240Issue #:Start Page: 44End Page: 56Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.007Best OA location URL: https://uvadoc.uva.es/handle/10324/63878Citation Count: 67
-
OPENTitle: ALS‐linked protein disulfide isomerase variants cause motor dysfunctionJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 35Issue #: 8Start Page: 845End Page: 865Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.201592224Best OA location URL: http://americanae.aecid.es/americanae/es/registros/registro.do?tipoRegistro=MTD&idBib=3455855Citation Count: 108
-
OPENTitle: Seeding activity of skin misfolded tau as a biomarker for tauopathiesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00781-1Best OA location URL: https://doi.org/10.1186/s13024-024-00781-1Citation Count: 5
- KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity2015OPENTitle: KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicityJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 31Start Page: 9596End Page: 9601Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1505953112Best OA location URL: https://www.pnas.org/content/pnas/112/31/9596.full.pdfCitation Count: 153
-
OPENTitle: An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant PathwaysJournal Name: Molecular & Cellular ProteomicsPublisher: Elsevier BVVol: 16Issue #: 4Start Page: 581End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1074/mcp.m116.061440Best OA location URL: https://www.mcponline.org/content/mcprot/16/4/581.full.pdfCitation Count: 66
- A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease2021OPENTitle: A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 63End Page: 72Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.023Best OA location URL: http://www.prd-journal.com/article/S1353802021002431/pdfCitation Count: 29
-
OPENTitle: Development of Pyridothiophene Compounds for PET Imaging of α‐SynucleinJournal Name: Chemistry – A European JournalPublisher: WileyVol: 30Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/chem.202303921Best OA location URL: https://doi.org/10.1002/chem.202303921Citation Count: 7
- Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms2021OPENTitle: Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanismsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 3Start Page: 553End Page: 578Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20200937Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/3/553/904049/bcj-2020-0937.pdfCitation Count: 44
-
OPENTitle: 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shorteningJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 25Issue #: 1Start Page: 109End Page: 122Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddv453Best OA location URL: https://academic.oup.com/hmg/article-pdf/25/1/109/7145789/ddv453.pdfCitation Count: 78
-
OPENTitle: Liganded magnetic nanoparticles for magnetic resonance imaging of α-synucleinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00918-zBest OA location URL: https://www.nature.com/articles/s41531-025-00918-z.pdfCitation Count: 0
-
OPENTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://n.neurology.org/content/neurology/73/20/1662.full.pdfCitation Count: 408
- Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model2025OPENTitle: Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse modelJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-025-02048-2Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-025-02048-2Citation Count: 0
-
OPENTitle: The Promise and Pitfalls of Facebook Advertising: a Genetic Counselor's PerspectiveJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 27Issue #: 2Start Page: 326End Page: 328Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0207-3Citation Count: 5
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression2021OPENTitle: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2444End Page: 2446Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28715Best OA location URL: https://doi.org/10.1002/mds.28715Citation Count: 50
-
OPENTitle: The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorderJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 43Issue #:Start Page: 180.e7End Page: 180.e13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.03.029Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4892956Citation Count: 14